Work with thought leaders and academic experts in Immunology
Companies can greatly benefit from working with experts in the field of Immunology. These researchers can provide valuable insights and expertise to enhance research and development efforts. They can help in the development of new drugs and therapies, conduct preclinical and clinical trials, and provide guidance on regulatory compliance. Additionally, Immunology experts can contribute to the understanding of disease mechanisms, identify potential biomarkers, and develop diagnostic tools. Their knowledge can also be applied in the fields of personalized medicine, immunotherapy, and vaccine development. Collaborating with Immunology researchers can lead to breakthrough discoveries, improved patient outcomes, and a competitive advantage in the healthcare industry.
Researchers on NotedSource with backgrounds in Immunology include Regan Hamel, Theresa Higgins, Dr. Lindsey Kuehm, Ph.D., Michael W Harman, Ping Luo, Joseph Bucukovski, Ph.D., Mohammad Imran Khan, Elvira Forte, Susan Song, MD/PhD, Odion Ikhimiukor, Brendan Monogue, Ph.D., Boris Leibovitch, Dr. David Siderovski, Ph.D., and Shariq Usmani, PhD.
Regan Hamel
Senior bioinformatics scientist, specializing in single cell omics in the context of cellular reprogramming and neuroinflammation
Education
University of Cambridge
PhD, Clinical Neurosciences / September, 2021
University of Cambridge
MPhil, Clinical Neurosciences / September, 2018
McGill University
Bachelor of Science, Neurosciences / June, 2017
Experience
Mogrify Ltd
Bioinformatics scientist / August, 2021 — June, 2023
Senior Bioinformatics Scientist / July, 2023 — Present
Most Relevant Research Expertise
Other Research Expertise (12)
About
Most Relevant Publications (2+)
12 total publications
Metabolic Control of Smoldering Neuroinflammation
Frontiers in Immunology / Jun 23, 2021
Peruzzotti-Jametti, L., Willis, C. M., Hamel, R., Krzak, G., & Pluchino, S. (2021). Metabolic Control of Smoldering Neuroinflammation. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.705920
Bioinformatics analysis identified apolipoprotein E as a hub gene regulating neuroinflammation in macrophages and microglia following spinal cord injury
Frontiers in Immunology / Aug 24, 2022
Yao, X.-Q., Chen, J.-Y., Yu, Z.-H., Huang, Z.-C., Hamel, R., Zeng, Y.-Q., Huang, Z.-P., Tu, K.-W., Liu, J.-H., Lu, Y.-M., Zhou, Z.-T., Pluchino, S., Zhu, Q.-A., & Chen, J.-T. (2022). Bioinformatics analysis identified apolipoprotein E as a hub gene regulating neuroinflammation in macrophages and microglia following spinal cord injury. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.964138
See Full Profile
Michael W Harman
Distinguished Subject Matter Expert & Leader in Medical Technologies.
Education
University of Connecticut
BS, Biomedical Engineering, Biofluid Mechanics Track / May, 2008
University of Connecticut
MS, Biomedical Engineering, Biomechanics Concentration / December, 2009
University of Arizona
Ph.D, Biochemistry, Molecular and Cellular Biology / December, 2015
Experience
Brown University
Postdoctoral Research Fellow / May, 2016 — August, 2018
Critical lead asset driving preclinical collaborative cell biomechanics study managing 30 personnel between immunology, pathobiology, and experimental soft matter mechanics laboratories.
Rhode Island Hospital
Postdoctoral Research Fellow / May, 2016 — August, 2018
Critical lead asset driving preclinical collaborative cell biomechanics study managing 30 personnel between immunology, pathobiology, and experimental soft matter mechanics laboratories.
Ximedica
Research & Development Engineer / September, 2018 — October, 2019
Provided technical subject matter expertise to enhance the clinical performance of novel medical products being designed.
Research & Development Engineering Manager / October, 2019 — July, 2020
Grew a team of Research & Development Engineers out of our traditional designer, mechanical, and electrical engineering departments to form a novel team within the organization and supported each of their individual professional development needs.
Most Relevant Research Expertise
Other Research Expertise (13)
About
Most Relevant Publications (1+)
15 total publications
The Hybrid Histidine Kinase Hk1 Is Part of a Two-Component System That Is Essential for Survival of Borrelia burgdorferi in Feeding Ixodes scapularis Ticks
Infection and Immunity / Aug 01, 2011
Caimano, M. J., Kenedy, M. R., Kairu, T., Desrosiers, D. C., Harman, M., Dunham-Ems, S., Akins, D. R., Pal, U., & Radolf, J. D. (2011). The Hybrid Histidine Kinase Hk1 Is Part of a Two-Component System That Is Essential for Survival of Borrelia burgdorferi in Feeding Ixodes scapularis Ticks. Infection and Immunity, 79(8), 3117–3130. https://doi.org/10.1128/iai.05136-11
See Full Profile
Ping Luo
Assistant Professor at Algoma University
Education
University of Saskatchewan
Ph.D., Biomedical Engineering / September, 2019
Beijing Institute of Technology
M.Eng., Biomedical Engineering / June, 2015
Hunan University
B.Eng., Computer Science / June, 2010
Experience
Princess Margaret Cancer Centre
Postdoctoral Researcher / November, 2019 — Present
I work in Dr. Trevor Pugh's lab and design cancer diagnosis and treatment strategies by analyze cell-free DNA and single cell sequencing data
Princess Margaret Cancer Centre
Bioinformatics Specialist / September, 2023 — Present
I work in Dr. Tak Mak's lab and study tumor immunology using single cell and TCR sequencing data.
Most Relevant Research Expertise
Other Research Expertise (21)
About
Most Relevant Publications (1+)
23 total publications
Normalization of the Immune Microenvironment during Lenalidomide Maintenance Is Associated with Sustained MRD Negativity in Patients with Multiple Myeloma
Blood / Nov 05, 2021
Coffey, D. G., Maura, F., Gonzalez-Kozlova, E., Diaz-Mejia3, J., Luo, P., Zhang, Y., Xu, Y., Warren, E. H., Smith, E. L., Cho, H. J., Lesokhin, A., Diamond, B., Kazandjian, D., Pugh, T. J., Green, D. J., Gnjatic, S., & Landgren, O. (2021). Normalization of the Immune Microenvironment during Lenalidomide Maintenance Is Associated with Sustained MRD Negativity in Patients with Multiple Myeloma. Blood, 138(Supplement 1), 329–329. https://doi.org/10.1182/blood-2021-154506
See Full Profile
Mohammad Imran Khan
Postdoctoral Associate at University of Maryland College Park in the Department of Nutrition and Food Science
Education
Kalinga Institute of Industrial Technology
PhD, School of Biotechnology / February, 2021
Kalinga Institute of Industrial Technology
M.Sc., Biotechnology / July, 2014
Experience
Columbia University Irving Medical Center, New York
Postdoctoral Research Scientist / August, 2021 — October, 2021
The George Washington University, Washington D.C.
Postdoctoral Associate / May, 2022 — March, 2023
University of Maryland College Park
Postdoctoral Associate / April, 2023 — Present
Most Relevant Research Expertise
Other Research Expertise (22)
About
Most Relevant Publications (1+)
11 total publications
Biogenic Au@ZnO core–shell nanocomposites kill Staphylococcus aureus without provoking nuclear damage and cytotoxicity in mouse fibroblasts cells under hyperglycemic condition with enhanced wound healing proficiency
Medical Microbiology and Immunology / Oct 05, 2018
Khan, Md. I., Behera, S. K., Paul, P., Das, B., Suar, M., Jayabalan, R., Fawcett, D., Poinern, G. E. J., Tripathy, S. K., & Mishra, A. (2018). Biogenic Au@ZnO core–shell nanocomposites kill Staphylococcus aureus without provoking nuclear damage and cytotoxicity in mouse fibroblasts cells under hyperglycemic condition with enhanced wound healing proficiency. Medical Microbiology and Immunology, 208(5), 609–629. https://doi.org/10.1007/s00430-018-0564-z
See Full Profile
Elvira Forte
Scientific strategist • Senior Scientist • Senior Scientific Editor
Education
Sapienza University of Rome
PhD, Pasteurian Sciences / January, 2011
Sapienza University of Rome
Master, Medical, Molecular and Cellular Biotechnology / October, 2006
Sapienza University of Rome
Bachelor, Biotechnology / October, 2004
Experience
Springer Nature
Associate/Senior Editor / June, 2021 — February, 2024
Helped shape and launch a new journal, Nature Cardiovascular Research, which publishes exceptional advances in the fields of cardiac, vascular, and blood biology, covering fundamental, translational, clinical, and public health research. • Assessed the novelty and impact of manuscripts within all the topics covered by the journal and chaperoned the whole revision process until acceptance for over 40% of all the content published by the journal since its start, with optimal processing times and excellent feedback from the authors. • Interfaced with scientists around the World, provided scientific guidance on how to improve manuscripts, or recommended more appropriate journals to publish with. Commissioned Comments, Reviews, News and Views on current topics, and summarized novel scientific findings in meaningful snippets and Research Highlights. • Contributed to the training and supervision of 2 Associate Editors; covered the Chief Editor's functions when needed.
Research Fellow/Associate Research Scientist / January, 2017 — June, 2021
• Analyzed the dynamic cellular changes during the fibrotic repair post-myocardial infarction, using cutting-edge techniques such as single-cell RNAseq with 10xChromium. Learned how to perform myocardial infarction in mice and assess the cardiac function via echography; analyze scRNAseq data using the Seurat package on R studio. • Completed a project aimed to characterize similarities and differences among fibroblasts from different organs cultured in the same conditions. Through cytometric, transcriptomic analysis, functional assays, shRNA and CRISPR-Cas9-mediated in vitro gene knockdowns we showed that fibroblasts isolated from different organs retain the expression of key transcription factors reflecting their embryological origin. • Collaborated with other laboratories in the Institute to design new mice models that could possibly recapitulate the symptoms of COVID-19; to analyze the response of mice with diverse genetic backgrounds to stressors.
Post-doctoral fellow/ Co-joint lecturer / May, 2013 — November, 2016
Developed projects aimed at understanding the embryological origin and function of a population of putative progenitor cells, cardiac colony forming unit fibroblasts cCFU-F, identified 2 years before in the lab (PMID: 22136928). • Performed cell lineage tracing and designed in vitro and in vivo cellular assays to assess the functional and immunomodulatory properties of PDGFRa+ fibroblasts in homeostasis and post-myocardial infarction with or without treatment with the PDGF-AB ligands. The data, presented in 3 international conferences and included in a preprint manuscript, have supported the use of a short-term treatment with PDGF-AB in a preclinical model of acute myocardial infarction in pigs. • Co-supervised 2 Ph.D. students at University of New South Wales
Scientific Editor / March, 2024 — Present
Consultant freelancer position within a team of former journal editors and grants specialists • Helped scientists increase the impact of their science by providing advice, in-depth editing, and feedback on manuscripts.
Most Relevant Research Expertise
Other Research Expertise (26)
About
Most Relevant Publications (2+)
63 total publications
HLA-DQ8 Supports Development of Insulitis Mediated by Insulin-Reactive Human TCR-Transgenic T Cells in Nonobese Diabetic Mice
The Journal of Immunology / Dec 15, 2023
Racine, J. J., Misherghi, A., Dwyer, J. R., Maser, R., Forte, E., Bedard, O., Sattler, S., Pugliese, A., Landry, L., Elso, C., Nakayama, M., Mannering, S., Rosenthal, N., & Serreze, D. V. (2023). HLA-DQ8 Supports Development of Insulitis Mediated by Insulin-Reactive Human TCR-Transgenic T Cells in Nonobese Diabetic Mice. The Journal of Immunology, 211(12), 1792–1805. https://doi.org/10.4049/jimmunol.2300303
Murine MHC-Deficient Nonobese Diabetic Mice Carrying Human HLA-DQ8 Develop Severe Myocarditis and Myositis in Response to Anti–PD-1 Immune Checkpoint Inhibitor Cancer Therapy
The Journal of Immunology / Mar 01, 2024
Racine, J. J., Bachman, J. F., Zhang, J.-G., Misherghi, A., Khadour, R., Kaisar, S., Bedard, O., Jenkins, C., Abbott, A., Forte, E., Rainer, P., Rosenthal, N., Sattler, S., & Serreze, D. V. (2024). Murine MHC-Deficient Nonobese Diabetic Mice Carrying Human HLA-DQ8 Develop Severe Myocarditis and Myositis in Response to Anti–PD-1 Immune Checkpoint Inhibitor Cancer Therapy. The Journal of Immunology, 212(8), 1287–1306. https://doi.org/10.4049/jimmunol.2300841
See Full Profile
Susan Song, MD/PhD
Research Assistant Professor in Neuroscience at University of Pittsburgh
Education
Southern Medical University
MD/PhD, Neurology, Neuroscience / June, 2015
University of Pittsburgh
Post-doc, Neuroscience / December, 2019
Experience
University of Pittsburgh
Research Assistant Professor / January, 2022 — Present
Research Instructor / January, 2020 — December, 2021
Postdoctoral Scholar / October, 2015 — December, 2019
Most Relevant Research Expertise
Other Research Expertise (15)
About
Most Relevant Publications (2+)
20 total publications
Attenuating vascular stenosis-induced astrogliosis preserves white matter integrity and cognitive function
Journal of Neuroinflammation / Aug 28, 2021
Liu, Q., Bhuiyan, M. I. H., Liu, R., Song, S., Begum, G., Young, C. B., Foley, L. M., Chen, F., Hitchens, T. K., Cao, G., Chattopadhyay, A., He, L., & Sun, D. (2021). Attenuating vascular stenosis-induced astrogliosis preserves white matter integrity and cognitive function. Journal of Neuroinflammation, 18(1). https://doi.org/10.1186/s12974-021-02234-8
Microglial–oligodendrocyte interactions in myelination and neurological function recovery after traumatic brain injury
Journal of Neuroinflammation / Oct 05, 2022
Song, S., Hasan, M. N., Yu, L., Paruchuri, S. S., Bielanin, J. P., Metwally, S., Oft, H. C. M., Fischer, S. G., Fiesler, V. M., Sen, T., Gupta, R. K., Foley, L. M., Hitchens, T. K., Dixon, C. E., Cambi, F., Sen, N., & Sun, D. (2022). Microglial–oligodendrocyte interactions in myelination and neurological function recovery after traumatic brain injury. Journal of Neuroinflammation, 19(1). https://doi.org/10.1186/s12974-022-02608-6
See Full Profile
Odion Ikhimiukor
Postdoctoral Research Scientist at University at Albany, State University of New York
Education
University of Ibadan
PhD Microbiology, Bacterial genomics, Bioinformatics, Microbiology
University of Ibadan
Master of Science (M. Sc.), Environmental Microbiology / April, 2015
University of Abuja
Bachelor of Science (B.Sc.), Microbiology / March, 2011
Experience
University at Albany, State University of New York
Postdoctoral Associate
National Institute for Pharmaceutical Research and Development
FCT Emergency Services, Asokoro District Hospital
Most Relevant Research Expertise
Other Research Expertise (23)
About
Most Relevant Publications (1+)
27 total publications
A bottom-up view of antimicrobial resistance transmission in developing countries
Nature Microbiology / May 30, 2022
Ikhimiukor, O. O., Odih, E. E., Donado-Godoy, P., & Okeke, I. N. (2022). A bottom-up view of antimicrobial resistance transmission in developing countries. Nature Microbiology, 7(6), 757–765. https://doi.org/10.1038/s41564-022-01124-w
See Full Profile
Boris Leibovitch
Experienced wet lab and in teaching Molecular Cell biologist, geneticist, cancer biologist in Academia
Education
Moscow Region State University
PhD, Molecular Biology / April, 1978
Moscow Region State University
MS, Genetics / July, 1972
Moscow Region State University
BS, Genetics / April, 1971
Experience
NYU Langone Medical Center
Associate Research Scientist / June, 2021 — September, 2022
Wet lab research and teaching Molecular and Cell Biology in MD program
Icahn School of Medicine at Mount Sinai
Assistant Professor / July, 2004 — June, 2021
Wet lab research and teaching Molecular and Cell Biology in MD program
Washington University in St. Louis
Post-doctoral Research Associate / June, 1994 — June, 2004
Wet lab research and teaching Molecular and Cell Biology in MS program
Most Relevant Research Expertise
Other Research Expertise (8)
About
Most Relevant Publications (1+)
22 total publications
The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor
Blood / Mar 15, 2008
Marango, J., Shimoyama, M., Nishio, H., Meyer, J. A., Min, D.-J., Sirulnik, A., Martinez-Martinez, Y., Chesi, M., Bergsagel, P. L., Zhou, M.-M., Waxman, S., Leibovitch, B. A., Walsh, M. J., & Licht, J. D. (2008). The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor. Blood, 111(6), 3145–3154. https://doi.org/10.1182/blood-2007-06-092122
See Full Profile
Dr. David Siderovski, Ph.D.
Professor of Computational Pharmacology; Chair of HSC SBS Dept. of Pharmacology & Neuroscience
Education
University of Toronto
Ph.D., Medical Biophysics / November, 1997
Experience
University of North Carolina at Chapel Hill
Professor / January, 1999 — June, 2012
West Virginia University School of Medicine
E.J. Van Liere Endowed Medicine Professor and Chairman / July, 2012 — February, 2020
Chair of the Dept. of Physiology and Pharmacology
University of North Texas Health Science Center
Professor & Chair / March, 2020 — Present
Most Relevant Research Expertise
Other Research Expertise (25)
About
Most Relevant Publications (2+)
94 total publications
The Mitochondrial Proteins NLRX1 and TUFM Form a Complex that Regulates Type I Interferon and Autophagy
Immunity / Jun 01, 2012
Lei, Y., Wen, H., Yu, Y., Taxman, D. J., Zhang, L., Widman, D. G., Swanson, K. V., Wen, K.-W., Damania, B., Moore, C. B., Giguère, P. M., Siderovski, D. P., Hiscott, J., Razani, B., Semenkovich, C. F., Chen, X., & Ting, J. P.-Y. (2012). The Mitochondrial Proteins NLRX1 and TUFM Form a Complex that Regulates Type I Interferon and Autophagy. Immunity, 36(6), 933–946. https://doi.org/10.1016/j.immuni.2012.03.025
A P-loop Mutation in Gα Subunits Prevents Transition to the Active State: Implications for G-protein Signaling in Fungal Pathogenesis
PLoS Pathogens / Feb 23, 2012
Bosch, D. E., Willard, F. S., Ramanujam, R., Kimple, A. J., Willard, M. D., Naqvi, N. I., & Siderovski, D. P. (2012). A P-loop Mutation in Gα Subunits Prevents Transition to the Active State: Implications for G-protein Signaling in Fungal Pathogenesis. PLoS Pathogens, 8(2), e1002553. https://doi.org/10.1371/journal.ppat.1002553
See Full Profile
Shariq Usmani, PhD
Massachusetts General Hospital, Harvard Medical School
Education
University of Konstanz
PhD, Molecular and Cell Biology / May, 2011
Harvard University
Postdoctoral fellow, Virology/Immunology / 2019
Experience
Cabaletta Bio
Scientific Director / 2024 — Present
I lead a research team in the preclinical R&D organization at Cabaletta bio. I directly manage a talented group of Senior Scientists, Scientists and Research Associates to spearhead and drive innovation in cell therapies and biologics in autoimmune disease indications.
Sana Biotechnology
Principal Scientist / 2022 — 2023
As a team lead, I led efforts to establish in vivo genome editing platform, vector design/engineering and optimization, with a broader goal to develop innovative and effective genomic medicine for unmet medical needs.
Zohdan Bio
Consultant / 2024 — Present
Providing strategic support for all aspects of preclinical, R&D programs in gene therapy, genome editing and virology and immunology space.
Most Relevant Research Expertise
Other Research Expertise (9)
About
Most Relevant Publications (7+)
22 total publications
Human Tetherin Exerts Strong Selection Pressure on the HIV-1 Group N Vpu Protein
PLoS Pathogens / Dec 20, 2012
Sauter, D., Unterweger, D., Vogl, M., Usmani, S. M., Heigele, A., Kluge, S. F., Hermkes, E., Moll, M., Barker, E., Peeters, M., Learn, G. H., Bibollet-Ruche, F., Fritz, J. V., Fackler, O. T., Hahn, B. H., & Kirchhoff, F. (2012). Human Tetherin Exerts Strong Selection Pressure on the HIV-1 Group N Vpu Protein. PLoS Pathogens, 8(12), e1003093. https://doi.org/10.1371/journal.ppat.1003093
Liquefaction of Semen Generates and Later Degrades a Conserved Semenogelin Peptide That Enhances HIV Infection
Journal of Virology / Jul 01, 2014
Roan, N. R., Liu, H., Usmani, S. M., Neidleman, J., Müller, J. A., Avila-Herrera, A., Gawanbacht, A., Zirafi, O., Chu, S., Dong, M., Kumar, S. T., Smith, J. F., Pollard, K. S., Fändrich, M., Kirchhoff, F., Münch, J., Witkowska, H. E., & Greene, W. C. (2014). Liquefaction of Semen Generates and Later Degrades a Conserved Semenogelin Peptide That Enhances HIV Infection. Journal of Virology, 88(13), 7221–7234. https://doi.org/10.1128/jvi.00269-14
Efficient Nef-Mediated Downmodulation of TCR-CD3 and CD28 Is Associated with High CD4 + T Cell Counts in Viremic HIV-2 Infection
Journal of Virology / May 01, 2012
Khalid, M., Yu, H., Sauter, D., Usmani, S. M., Schmokel, J., Feldman, J., Gruters, R. A., van der Ende, M. E., Geyer, M., Rowland-Jones, S., Osterhaus, A. D., & Kirchhoff, F. (2012). Efficient Nef-Mediated Downmodulation of TCR-CD3 and CD28 Is Associated with High CD4 + T Cell Counts in Viremic HIV-2 Infection. Journal of Virology, 86(9), 4906–4920. https://doi.org/10.1128/jvi.06856-11
Molecular basis of early epithelial response to streptococcal exotoxin: role of STIM1 and Orai1 proteins
Cellular Microbiology / Dec 13, 2011
Usmani, S. M., von Einem, J., Frick, M., Miklavc, P., Mayenburg, M., Husmann, M., Dietl, P., & Wittekindt, O. H. (2011). Molecular basis of early epithelial response to streptococcal exotoxin: role of STIM1 and Orai1 proteins: Streptolysin O activates SOC entry. Cellular Microbiology, 14(3), 299–315. https://doi.org/10.1111/j.1462-5822.2011.01724.x
Lentiviral Nef Proteins Manipulate T Cells in a Subset-Specific Manner
Journal of Virology / Feb 15, 2015
Yu, H., Khalid, M., Heigele, A., Schmökel, J., M. Usmani, S., van der Merwe, J., Münch, J., Silvestri, G., & Kirchhoff, F. (2015). Lentiviral Nef Proteins Manipulate T Cells in a Subset-Specific Manner. Journal of Virology, 89(4), 1986–2001. https://doi.org/10.1128/jvi.03104-14
Cancer cells relax and resist cytotoxic attack
Immunity / May 01, 2021
Usmani, S. M., & Mempel, T. R. (2021). Cancer cells relax and resist cytotoxic attack. Immunity, 54(5), 853–855. https://doi.org/10.1016/j.immuni.2021.04.017
HIV-enhancing Amyloids Are Prevalent in Fresh Semen and Are a Determinant for Semen's Ability to Enhance HIV Infection: Relevance for HIV Transmission
AIDS Research and Human Retroviruses / Oct 01, 2014
Usmani, S., Liu, H., Pilcher, C. D., Witkowska, H. E., Kirchhoff, F., Greene, W. C., Münch, J., & Roan, N. R. (2014). HIV-enhancing Amyloids Are Prevalent in Fresh Semen and Are a Determinant for Semen’s Ability to Enhance HIV Infection: Relevance for HIV Transmission. AIDS Research and Human Retroviruses, 30(S1), A183–A184. https://doi.org/10.1089/aid.2014.5392.abstract
See Full Profile
Example Immunology projects
How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on Immunology?
Development of Novel Immunotherapies
An Immunology expert can collaborate with a pharmaceutical company to develop novel immunotherapies for the treatment of cancer and autoimmune diseases. Their expertise in understanding the immune system and its response to diseases can help in identifying new targets and designing effective therapies.
Drug Discovery and Development
Companies can collaborate with Immunology researchers to discover and develop new drugs. These experts can provide insights into disease mechanisms, identify potential drug targets, and evaluate the efficacy and safety of drug candidates through preclinical and clinical trials.
Biomarker Identification
Immunology experts can assist companies in identifying biomarkers that can be used for disease diagnosis, prognosis, and monitoring. These biomarkers can help in early detection, personalized treatment approaches, and assessing treatment response.
Vaccine Development
Collaborating with Immunology researchers can accelerate the development of vaccines. Their knowledge of immune responses to pathogens can aid in the design and optimization of vaccines, ensuring their effectiveness and safety.
Personalized Medicine
Immunology experts can contribute to the field of personalized medicine by understanding individual variations in immune responses. This knowledge can help in tailoring treatment approaches based on a patient's immune profile, leading to improved therapeutic outcomes.